Multicenter phase II study of oral S-1 monotherapy in advanced colorectal cancer who have failed prior oxaliplatin and irinotecan-based therapies

ABSTRACT: Interventions: S-1 monotherapy Primary outcome(s): Progression free survival Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2621918 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR